Found: 6
Select item for more details and to access through your institution.
Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation.
- Published in:
- Science Translational Medicine, 2017, v. 9, n. 385, p. 1, doi. 10.1126/scitranslmed.aak9679
- By:
- Publication type:
- Article
A dose-dependent plasma signature of the safety and immunogenicity of the rVSV-Ebola vaccine in Europe and Africa.
- Published in:
- Science Translational Medicine, 2017, v. 9, n. 385, p. 1, doi. 10.1126/scitranslmed.aaj1701
- By:
- Publication type:
- Article
Longitudinal peripheral blood transcriptional analysis of a patient with severe Ebola virus disease.
- Published in:
- Science Translational Medicine, 2017, v. 9, n. 385, p. 1, doi. 10.1126/scitranslmed.aai9321
- By:
- Publication type:
- Article
Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade.
- Published in:
- Science Translational Medicine, 2017, v. 9, n. 385, p. 1, doi. 10.1126/scitranslmed.aak9670
- By:
- Publication type:
- Article
Individuals with progranulin haploinsufficiency exhibit features of neuronal ceroid lipofuscinosis.
- Published in:
- Science Translational Medicine, 2017, v. 9, n. 385, p. 1, doi. 10.1126/scitranslmed.aah5642
- By:
- Publication type:
- Article
Engagement of the medical-technology sector with society.
- Published in:
- Science Translational Medicine, 2017, v. 9, n. 385, p. 1, doi. 10.1126/scitranslmed.aal4359
- By:
- Publication type:
- Article